Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Onychomycosis
Age: Adult
Dose: Oral – 250 mg
Frequency: once daily
Duration: 6 weeks (fingernail) or 12 weeks (toenail)
Note: Hepatic impairment: Use not recommended in chronic or active liver disease
Indication: Tinea Pedis
Age: Adult
Dose: Oral – 250 mg/day
Frequency: by mouth in single dose or divided every 12 hours
Duration: 2-6 weeks
Note: Hepatic impairment: Use not recommended in chronic or active liver disease

Child Dose

Clinical InformationAdministration Information
Indication: Tinea Capitis
Age: greater than 4 years
Dose: Oral – 125 mg/day
Frequency: once daily
Duration: 6 weeks
Note: by mouth (oral)
Indication: Tinea Capitis
Age: greater than 4 years
Dose: Oral – 187.5 mg/day
Frequency: once daily
Duration: 6 weeks
Note: by mouth (oral)

Renal Dose

Clinical InformationAdministration Information
Condition: Renal impairment
Dose: Use not recommended
Note: If creatinine clearance less than 50 mL/min
Administration
  • Can be taken with or without food
  • Complete prescribed course
Side Effect

Drug Interaction

Drug NameRisk Factors
CYP450 2D6 metabolized drugs
Possible increase in levels
Rifampicin
Decreased terbinafine concentration

Disease Interaction

Disease NameRisk Factors
Active/Chronic Liver Disease
Can cause liver damage

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage

Details coming soon

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.